Evidence map›Paper›PMID 38980534›Full record

ArticleThe protein journal2024

Conjugation with the Carrier Helped to Reveal acidification-Induced Structural Shift in the Peptide from Phospholipase Domain of Parvovirus B19.

Vladislav Victorovich Khrustalev, Olga Victorovna Khrustaleva, Aleksander Nicolaevich Stojarov, Anastasia Aleksandrovna Akunevich, Oleg Evgenyevich Baranov, Anna Vladimirovna Popinako, Elena Olegovna Samoilovich, Marina Anatolyevna Yermolovich, Galina Valeryevna Semeiko, Victoria Igorevna Cheprasova and 7 more

Abstract read
PubMed Publisher
In one paragraph

Article in The protein journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Vladislav Victorovich KhrustalevDepartment of General Chemistry, Belarusian State Medical University, Dzerzhinskogo 83, Minsk, 220045, 220083, Belarus. vvkhrustalev@mail.ru.
Olga Victorovna KhrustalevaDepartment of General Chemistry, Belarusian State Medical University, Dzerzhinskogo 83, Minsk, 220045, 220083, Belarus.
Aleksander Nicolaevich StojarovDepartment of Radiation Medicine and Ecology, Belarusian State Medical University, Dzerzhinskogo 83, Minsk, 220045, Belarus.
Anastasia Aleksandrovna AkunevichDepartment of General Chemistry, Belarusian State Medical University, Dzerzhinskogo 83, Minsk, 220045, 220083, Belarus.
Oleg Evgenyevich BaranovBach Institute of Biochemistry, Shared-Access Equipment Centre "Industrial Biotechnology" of Russian Academy of Science, Leninskiy prospect, 33/2, Moscow, 119071, Russian Federation.
Anna Vladimirovna PopinakoBach Institute of Biochemistry, Research Center of Biotechnology of the Russian Academy of Sciences, Leninskiy prospect, 33/2, Moscow, 119071, Russian Federation.
Elena Olegovna SamoilovichLaboratory of Vaccine-controlled Infections, Republican Research and Practical Center for Epidemiology and Microbiology, Filimonova 23, Minsk, 220114, Belarus.
Marina Anatolyevna YermolovichLaboratory of Vaccine-controlled Infections, Republican Research and Practical Center for Epidemiology and Microbiology, Filimonova 23, Minsk, 220114, Belarus.
Galina Valeryevna SemeikoLaboratory of Vaccine-controlled Infections, Republican Research and Practical Center for Epidemiology and Microbiology, Filimonova 23, Minsk, 220114, Belarus.
Victoria Igorevna CheprasovaLaboratory of infra-red spectroscopy and infra-red microscopy, Belarusian State Technological University, Sverdlova 13a, Minsk, 220006, Belarus.
Egor Gennadyevich SaponLaboratory of infra-red spectroscopy and infra-red microscopy, Belarusian State Technological University, Sverdlova 13a, Minsk, 220006, Belarus.
Nikolai Vladimirovich ShalygoDepartment of General Chemistry, Belarusian State Medical University, Dzerzhinskogo 83, Minsk, 220045, 220083, Belarus.
Victor Vitoldovich PoboinevDepartment of General Chemistry, Belarusian State Medical University, Dzerzhinskogo 83, Minsk, 220045, 220083, Belarus.
Tatyana Aleksandrovna KhrustalevaLaboratory of Biomedical Technologies and Medical Rehabilitation, Institute of Physiology of the National Academy of Sciences of Belarus, Academicheskaya 28, Minsk, 220072, Belarus.
Bahdan Vyacheslavovich RanishenkaLaboratory of Chemistry of Bioconjugates, Institute of Physical-organic Chemistry of the National Academy of Sciences of Belarus, Surganova 13, Minsk, 220072, Belarus.
Ulyana Vitalyevna KharytonovaDepartment of General Chemistry, Belarusian State Medical University, Dzerzhinskogo 83, Minsk, 220045, 220083, Belarus.
Daniel BushDepartment of General Chemistry, Belarusian State Medical University, Dzerzhinskogo 83, Minsk, 220045, 220083, Belarus.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Spectroscopic studies on domains and peptides of large proteins are complicated because of the tendency of short peptides to form oligomers in aquatic buffers, but conjugation of a peptide with a carrier protein may be helpful. In this study we approved that a fragment of SK30 peptide from phospholipase A2 domain of VP1 Parvovirus B19 capsid protein (residues: 144-159; 164; 171-183; sequence: SAVDSAARIHDFRYSQLAKLGINPYTHWTVADEELLKNIK) turns from random coil to alpha helix in the acidic medium only in case if it had been conjugated with BSA (through additional N-terminal Cys residue, turning it into CSK31 peptide, and SMCC linker) according to CD-spectroscopy results. In contrast, unconjugated SK30 peptide does not undergo such shift because it forms stable oligomers connected by intermolecular antiparallel beta sheet, according to IR-spectroscopy, CD-spectroscopy, blue native gel electrophoresis and centrifugal ultrafiltration, as, probably, the whole isolated phospholipase domain of VP1 protein does. However, being a part of the long VP1 capsid protein, phospholipase domain may change its fold during the acidification of the medium in the endolysosome by the way of the formation of contacts between protonated His153 and Asp175, promoting the shift from random coil to alpha helix in its N-terminal part. This study opens up a perspective of vaccine development, since rabbit polyclonal antibodies against the conjugate of CSK31 peptide with BSA, in which the structure of the second alpha helix from the phospholipase A2 domain should be reproduced, can bind epitopes of the complete recombinant unique part of VP1 Parvovirus B19 capsid (residues: 1-227).

Indexed as

Capsid ProteinsParvovirus B19, HumanAnimalsHydrogen-Ion ConcentrationPeptidesPhospholipases A2Protein DomainsSerum Albumin, BovineCapsid Proteinscapsid protein VP1, parvovirus B19PeptidesPhospholipases A2Serum Albumin, BovineParvovirus B19Phospholipase A2Random coil to alpha helix transitionSynthetic peptidesViral entrance

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.